oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes SOUL: Bests Usual Care Oral Semaglutide Reduces Cardiovascular Events

doi:10.1016/S1474-4422(20)30231-3 186

Best for: Patients who need ongoing metabolic support Those with a history of weight cycling Signs You May Be Ready to Taper or Pause Youve reached your goal weight and maintained it for 23 months Youre consistently eating balanced meals and feeling in control of your appetite Youre physically active and have healthy lifestyle habits in place You feel stable in your mental and emotional relationship with food Work with your provider to gradually reduce your dose , rather than stopping cold turkey

In addition to direct conjugation to nanoparticles that have been mentioned in previous sections, targeting ligands are also able to assemble into the nanostructures in assistance with polymers to accomplish the goals of targeted drug delivery

It can lessen the symptoms of acute liver failure and stop cirrhosis from progressing